Search results
Investors in U.S. Physical Therapy (NYSE:USPH) have unfortunately lost 5.7% over the last five years
Simply Wall St. via Yahoo Finance· 6 hours agoI find it very interesting to look at share price over the long term as a proxy for business...
Analyst unveils Amgen stock price target after weight-loss drug data
TheStreet via Yahoo Finance· 46 minutes agoThe firm has grown more confident in the therapy's potential to meaningfully differentiate it from...
Where Is Amgen Headed After the Stock Surges on Obesity Drug News?
TheStreet.com· 7 hours agoThe company also "tweaked" their forward guidance and the stock was raised to a fundamental...
Intra-Cellular Therapies Inc (ITCI) Shares Plummet Below 1-Year High – News Heater
NewsHeater· 14 hours agoThe stock of Intra-Cellular Therapies Inc (NASDAQ: ITCI) has decreased by -3.29 when compared to last closing price of 72.73. Despite this, the company has experienced a - ...
Citi Just Cut Its Price Target on These 3 Stocks
InvestorPlace· 1 hour agoAmid the current earnings season, with brokers actively revisingprice targets, Citigroup (NYSE:C) recently reduced its 12-month targets for several...
Earnings call: TG Therapeutics sees strong Q1 growth with Briumvi By Investing.com
Investing.com· 6 hours agoTG Therapeutics (NASDAQ:TGTX) has reported a robust first quarter in 2024, with Briumvi, its...
Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q1 Earnings? What You Should Know
Zacks via Yahoo Finance· 1 day agoTaysha Gene Therapies (TSHA) doesn't possess the right combination of the two key ingredients for a...
Novo Nordisk A/S (NYSE:NVO) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 23 minutes agoNovo Nordisk A/S (NYSE:NVO) Q1 2024 Earnings Call Transcript May 2, 2024 Novo Nordisk A/S misses on...
Think You Need A Good Stock? Look At This Taysha Gene Therapies Inc
Stocks Register· 3 days agoLong term indicators on average place the stock in the category of 100% Buy. Looking further, we note the current price level is -7.56% off its SMA20 and ...
Taysha Gene Therapies Inc (TSHA) receives an Overweight rating from Piper Sandler – Knox Daily
Knox Daily· 4 days agoB now holds 16,466,667 shares, worth roughly $39.36 million. Piper Sandler initiated its Taysha Gene Therapies Inc [TSHA] rating to an Overweight in a research note published ...